Overview
Syndromic craniosynostosis refers to a group of rare genetic disorders characterized by the premature fusion of one or more cranial sutures (craniosynostosis) occurring in combination with other congenital anomalies affecting multiple organ systems. Unlike isolated (non-syndromic) craniosynostosis, syndromic forms present with additional features such as limb abnormalities (particularly of the hands and feet), facial dysmorphism, and sometimes intellectual disability or developmental delay. Well-known subtypes falling under this umbrella include Apert syndrome, Crouzon syndrome, Pfeiffer syndrome, Muenke syndrome, Saethre-Chotzen syndrome, and others, each with distinct clinical profiles. The premature fusion of skull sutures restricts normal skull growth, leading to abnormal head shape and potentially raised intracranial pressure, which can threaten brain development and vision if untreated. Midface hypoplasia (underdevelopment of the middle portion of the face) is common across many syndromic forms, contributing to airway obstruction, obstructive sleep apnea, feeding difficulties, and exophthalmos (bulging eyes). Hearing loss, dental malocclusion, and hydrocephalus may also occur. Limb anomalies range from broad thumbs and great toes (Pfeiffer syndrome) to syndactyly or fusion of fingers and toes (Apert syndrome). Most syndromic craniosynostoses are caused by gain-of-function mutations in genes encoding fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) or the TWIST1 transcription factor, and are typically inherited in an autosomal dominant pattern, though many cases arise from de novo mutations. Management is multidisciplinary and often requires staged surgical interventions including cranial vault remodeling to relieve intracranial pressure, midface advancement procedures, and correction of limb anomalies. Supportive care may include ophthalmologic monitoring, speech therapy, hearing aids, and neurodevelopmental support. Early diagnosis and coordinated care by craniofacial teams significantly improve outcomes.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Syndromic craniosynostosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Syndromic craniosynostosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Syndromic craniosynostosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Syndromic craniosynostosis.
Community
No community posts yet. Be the first to share your experience with Syndromic craniosynostosis.
Start the conversation →Latest news about Syndromic craniosynostosis
No recent news articles for Syndromic craniosynostosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Syndromic craniosynostosis
What is Syndromic craniosynostosis?
Syndromic craniosynostosis refers to a group of rare genetic disorders characterized by the premature fusion of one or more cranial sutures (craniosynostosis) occurring in combination with other congenital anomalies affecting multiple organ systems. Unlike isolated (non-syndromic) craniosynostosis, syndromic forms present with additional features such as limb abnormalities (particularly of the hands and feet), facial dysmorphism, and sometimes intellectual disability or developmental delay. Well-known subtypes falling under this umbrella include Apert syndrome, Crouzon syndrome, Pfeiffer syndr
At what age does Syndromic craniosynostosis typically begin?
Typical onset of Syndromic craniosynostosis is neonatal. Age of onset can vary across affected individuals.